Thomas Jaki

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

Bin Cao, Yeming Wang, Danning Wen et al. · New England Journal of Medicine · 2020 · 5.5K citations · Full text

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Yeming Wang, Dingyu Zhang, Guanhua Du et al. · The Lancet · 2020 · 3.6K citations · Full text

Treatment And Prevention, Covid-19 Pandemic, Clinical Trials +9

Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Peter Horby, Wei Shen Lim, Jonathan Emberson et al. · 2020 · 842 citations · Full text

Diffuse Lung Damage, Pulmonary Care, Clinical Infectious Disease +11

Adaptive designs in clinical trials: why use them, and how to run and report them

Philip Pallmann, Alun Bedding, Babak Choodari‐Oskooei et al. · BMC Medicine · 2018 · 764 citations · Full text

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Peter Horby, Marion Mafham, Jennifer Bell et al. · The Lancet · 2020 · 741 citations · Full text